cyclic-gmp and Leukemia--Promyelocytic--Acute

cyclic-gmp has been researched along with Leukemia--Promyelocytic--Acute* in 4 studies

Other Studies

4 other study(ies) available for cyclic-gmp and Leukemia--Promyelocytic--Acute

ArticleYear
Effects of cAMP and cGMP elevating agents on HL-60 cell differentiation.
    Pharmacology & toxicology, 1994, Volume: 75, Issue:2

    Previous studies have demonstrated low percentage of HL-60 cell differentiation with theophylline. The present study demonstrate that millimolar concentrations of the non-selective phosphodiesterase inhibitors theophylline, caffeine and isobutyl-methylxanthine all inhibit growth, induce substantial differentiation and elevation of both cAMP and cGMP in HL-60 cells. Selective inhibition of cAMP hydrolysis by Ro20-1724 was without effect. The guanylate cyclase stimulator sodium nitroprusside, which increased cGMP only poorly and also increased cAMP, produced growth inhibition but no differentiation. We put forward the hypothesis that elevation of both cAMP and cGMP above a critical level is necessary for significant cyclic nucleotide induced HL-60 cell differentiation.

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Cell Differentiation; Cell Division; Cyclic AMP; Cyclic GMP; Humans; Leukemia, Promyelocytic, Acute; Nitroprusside; Phosphodiesterase Inhibitors; Tumor Cells, Cultured

1994
Stimulation of phosphoinositol turnover and protein kinase C activation by granulocyte-macrophage colony-stimulating factor in HL-60 cells.
    Blood, 1992, Aug-15, Volume: 80, Issue:4

    Phosphoinositol turnover, diacylglycerol generation, protein kinase C (PK-C) activity, and intracellular cyclic nucleotides were studied in an established human leukemia cell line, HL-60, in response to one of the hematopoietic cytokines, granulocyte-macrophage colony-stimulating factor (GM-CSF). Continuous exposure of HL-60 cells to GM-CSF induced the cell differentiation that was evaluated by the nitroblue tetrazolium (NBT) reducing activity. GM-CSF also exhibited a proliferative effect on HL-60 cells. GM-CSF at 1 nmol/L, an optimal concentration for cell growth and cell differentiation, induced significant changes in the intracellular inositoltriphosphate (IP3). Diacylglycerol generation was also stimulated by GM-CSF treatment. GM-CSF increased the membrane PK-C activity by 10-fold of the control, whereas no measurable change in cyclic nucleotides was observed. These data indicated that phosphoinositol turnover and the activation of PK-C were included in the GM-CSF signal transducing pathway in HL-60 cell. Phosphoinositol response leading to PK-C activation may act as a trigger signal of cell differentiation by GM-CSF.

    Topics: Cell Differentiation; Cell Division; Cyclic AMP; Cyclic GMP; Diglycerides; Enzyme Activation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inositol Phosphates; Kinetics; Leukemia, Promyelocytic, Acute; Protein Kinase C; Signal Transduction; Tumor Cells, Cultured

1992
Studies on monoclonal anti-isotypic and anti-idiotypic antibodies against leukemia and myeloma: V. The effects of monoclonal antibodies and interferon on the levels of cyclic nucleotides in leukemic cell lines.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1992, Volume: 12, Issue:4

    After the leukemic cell lines were treated with monoclonal antibodies (McAbs) and interferon (IFN-alpha), the changes of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels in the corresponding leukemic cell lines were measured by radioimmunoassay. The results showed that when the ratio of antigen to antibody was 80 to 1, the cAMP levels in the leukemic cell lines were obviously higher than those in the controls while the cGMP levels were obviously lower after being treated with the corresponding McAbs for 16-24 h (P < 0.001). The average level of intracellular cAMP was remarkably increased and that of cGMP underwent no significant changes in the leukemic cell lines after treatment with IFN-alpha.

    Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Cyclic AMP; Cyclic GMP; Humans; Immunoglobulin Isotypes; Interferon-alpha; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Promyelocytic, Acute; Plasmacytoma; Tumor Cells, Cultured

1992
cGMP-induced differentiation of the promyelocytic cell line HL-60.
    Proceedings of the National Academy of Sciences of the United States of America, 1989, Volume: 86, Issue:18

    cGMP is a second messenger that mediates numerous metabolic events; in the present work a role in myeloid cell differentiation was demonstrated. Nitroprusside and NaNO2, which activate cytosolic guanylate cyclase and increase the intracellular cGMP concentration, induced granulocytic differentiation of the human promyelocytic cell line HL-60; differentiation was measured by acquisition of the OKM1 antigen, morphological changes, and nitroblue tetrazolium reduction. When theophylline, a phosphodiesterase inhibitor, which by itself induced modest differentiation, was added to nitroprusside or NaNO2, differentiation increased in an additive fashion. The degree of differentiation correlated with the increase in the intracellular cGMP concentration. 8-Bromoguanosine 3',5'-cyclic monophosphate, a membrane-permeable cGMP analogue, also induced differentiation of HL-60 cells but was much more effective in the presence of theophylline, with the two agents interacting synergistically. The effect of theophylline in these studies could not be attributed to increasing the intracellular cAMP concentration. Dimethyl sulfoxide, and established inducer of differentiation of HL-60 cells, markedly enhanced the differentiation induced by nitroprusside and NaNO2.

    Topics: Cell Differentiation; Cell Line; Cyclic AMP; Cyclic GMP; Flow Cytometry; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Nitroprusside; Second Messenger Systems; Sodium Nitrite; Theophylline

1989